PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35250023-3	2022	The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.	AZD 6244	21-28	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	40-44